Voit & Company’s CVS Health CVS Stock Holding History

Voit & Company’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,700	Closed	-$308K	–	85
2018 Q4	$308K	Buy	+4,700	New	+$351K	0.39%	45

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voit & Company's CVS Position: Q1 2019 in Review

Voit & Company sold out of CVS Health (CVS) in Q1 2019, closing a stake of 4,700 shares — an estimated $308K sold.

Voit & Company first reported a position in CVS in Q4 2018 and held it in 1 quarter. The position peaked at $308K in Q4 2018. 1,707 funds tracked by Wall St. Rank hold CVS as of Q1 2019.

Voit & Company reported no remaining CVS Health position as of Q1 2019 after selling out during the quarter.
Voit & Company sold 4,700 CVS Health shares in Q1 2019, an estimated $308K.
Voit & Company first reported a position in CVS Health in Q4 2018 and held it in 1 quarter.
Voit & Company's CVS Health position peaked at $308K in Q4 2018.
1,707 funds tracked by Wall St. Rank held CVS Health as of Q1 2019.

Based on Voit & Company's 13F filing for Q1 2019, filed 3 May 2019.